Back

AI Generated Stromal Biomarkers for DCIS Reccurence Prediction

2026-02-17 oncology Title + abstract only
View on medRxiv
Show abstract

BackgroundAlthough DCIS has a relatively low recurrence rate, many patients still receive adjuvant radiotherapy or endocrine therapy, raising concerns about overtreatment. Reliable biomarkers are therefore needed to predict an individual patients risk and guide treatment decisions. Recent studies suggest that the composition of the tumour-associated stroma (TAS) affects progression and outcome, highlighting TAS-derived biomarkers as promising candidates for further investigation. MethodsWe trai...

Predicted journal destinations